Attention Deficit Hyperactivity Disorder
GPTKB entity
Statements (51)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:advocacy |
gptkb:educational_resources
support groups awareness campaigns |
gptkbp:affects |
gptkb:children
adults academic challenges employment issues relationship difficulties |
gptkbp:cause |
environmental factors
genetic factors brain structure differences |
gptkbp:community_health |
bipolar disorder
conduct disorder oppositional defiant disorder |
gptkbp:condition |
gptkb:depression
anxiety disorders learning disabilities |
gptkbp:diagnosis |
gptkb:ICD-10
gptkb:DSM-5 clinical assessment |
gptkbp:famous_person |
gptkb:Justin_Randall_Timberlake
gptkb:Michael_Phelps gptkb:Jim_Carrey gptkb:Solange_Knowles gptkb:Cher |
gptkbp:gender |
more common in boys
|
https://www.w3.org/2000/01/rdf-schema#label |
Attention Deficit Hyperactivity Disorder
|
gptkbp:medication_type |
stimulants
non-stimulants |
gptkbp:premiered_on |
early childhood
|
gptkbp:prevalence |
2.5% of adults
5% of children |
gptkbp:public_perception |
misunderstood condition
stigmatized condition |
gptkbp:research_areas |
neurobiology
psychosocial interventions psychopharmacology |
gptkbp:symptoms |
impulsivity
hyperactivity inattention |
gptkbp:treatment |
gptkb:pharmaceuticals
gptkb:psychotherapy cognitive behavioral therapy social skills training parent training |
gptkbp:bfsParent |
gptkb:Focalin_XR
gptkb:Metadate_CD gptkb:Atomoxetine gptkb:CHADD |
gptkbp:bfsLayer |
6
|